CN Stock MarketDetailed Quotes

600511 China National Medicines Corporation

Watchlist
  • 34.84
  • +0.19+0.55%
Trading Dec 23 10:52 CST
26.29BMarket Cap12.14P/E (TTM)

China National Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China National Medicines Corporation Q3 2024 Earnings Date

Currency：CNYOct 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
13.51B
13.27B
-232.96M
Miss Est.
--
+7.12%
-1.73%
EPS
--
0.64
--
--
Analyst Rating
Strong Buy

Dec 22, 2024

China National Medicines Corporation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 12.852B --
-- 2024/Q4 -- / 14.649B --
Oct 24, 2024 2024/Q3 13.272B / 13.505B --
Aug 22, 2024 2024/Q2 12.634B / 14.076B --
Apr 26, 2024 2024/Q1 12.122B / 12.237B --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.852B--
--2024/Q4-- / 14.649B--
Oct 24, 20242024/Q313.272B / 13.505B--
Aug 22, 20242024/Q212.634B / 14.076B--
Apr 26, 20242024/Q112.122B / 12.237B--

Unlock Free Earnings Estimates

China National Medicines Corporation Earnings Reports

  • Sinopharm: Sinopharm Report for the Third Quarter of 2024

    Oct 24 00:00

  • Sinopharm Report for the Third Quarter of 2024

    Oct 24 00:00

  • China National Medicines Corporation Semi-Annual Report for 2024

    Aug 22 00:00

  • 国药股份2024年半年度报告摘要

    Aug 22 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Strong Buy

    • Strong Buy

      81.82%

    • Buy

      18.18%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme MSCI concept
    MSCI concept
    Intraday+0.96%
    ShangHai Stock Connect
    ShangHai Stock Connect
    Intraday+0.81%
    State-owned Enterprise Reform
    State-owned Enterprise Reform
    Intraday+0.67%